Myocarditis risk from Pfizer vaccine appears low in kids, says specialist

• 3 years ago
• News
• Duration 4:16

A review of data suggests the Pfizer-BioNTech COVID-19 poses a very low risk of heart inflammation in children, says cardiologist Christopher Labos. Pfizer is seeking approval of its vaccine for ages five to 11 in the U.S. (Esteban Felix/The Associated Press)